ScholarIQanswers from OpenAlex

Immunotherapy in Advanced Gastric Cancer: Advancing Precision Medicine and Emerging Therapeutic Strategies

PaperCitations, authors & open-access status

Immunotherapy in Advanced Gastric Cancer: Advancing Precision Medicine and Emerging Therapeutic Strategies is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Immunotherapy in Advanced Gastric Cancer: Advancing Precision Medicine and Emerging Therapeutic Strategies have?

ScholarIQcitation count

Immunotherapy in Advanced Gastric Cancer: Advancing Precision Medicine and Emerging Therapeutic Strategies has 0 citations in the OpenAlex counts ScholarIQ stores.

When was Immunotherapy in Advanced Gastric Cancer: Advancing Precision Medicine and Emerging Therapeutic Strategies published?

ScholarIQyear

Immunotherapy in Advanced Gastric Cancer: Advancing Precision Medicine and Emerging Therapeutic Strategies has 2026 year in the ScholarIQ index.

Open the OpenAlex record →

What is the open-access status of Immunotherapy in Advanced Gastric Cancer: Advancing Precision Medicine and Emerging Therapeutic Strategies?

ScholarIQoa status

Immunotherapy in Advanced Gastric Cancer: Advancing Precision Medicine and Emerging Therapeutic Strategies has diamond oa status in the ScholarIQ index.

Open the OpenAlex record →

What is the DOI of Immunotherapy in Advanced Gastric Cancer: Advancing Precision Medicine and Emerging Therapeutic Strategies?

ScholarIQdoi

The DOI for Immunotherapy in Advanced Gastric Cancer: Advancing Precision Medicine and Emerging Therapeutic Strategies is on the source record.

Open the DOI →

What is the OpenAlex record for Immunotherapy in Advanced Gastric Cancer: Advancing Precision Medicine and Emerging Therapeutic Strategies?

ScholarIQopenalex

The OpenAlex for Immunotherapy in Advanced Gastric Cancer: Advancing Precision Medicine and Emerging Therapeutic Strategies is on the source record.

Open the OpenAlex →